Patents by Inventor Matthew A. Hostetler

Matthew A. Hostetler has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • BIOACTIVE PEPTIDE MOLECULES DISCOVERED BY A COMBINATION OF BIOINFORMATICS TECHNIQUE AND CHEMICAL SYNTHESIS
    Publication number: 20240101995
    Abstract: The present disclosure teaches a method of treating a patient in need of therapeutic intervention with bioactive cyclic peptide molecules which are useful as antimicrobials, anticancer agents, antiparasitic, immunosuppressants, and others.
    Type: Application
    Filed: November 30, 2023
    Publication date: March 28, 2024
    Applicant: Purdue Research Foundation
    Inventors: Elizabeth I. Parkinson, Matthew A. Hostetler
  • Bioactive peptide molecules discovered by a combination of bioinformatics technique and chemical synthesis
    Patent number: 11879142
    Abstract: The present disclosure reaches a method of a unique combination of bioinformatic technical tools together with chemical synthesis for identification of bioactive peptide molecules based on non-ribosomal peptide synthetases. Those bioactive cyclic peptide molecules are useful as antimicrobials, anticancer agents, antiparasitic, immunosuppressants, and others. Series of useful cyclic peptides and the pharmaceutical compositions thereof are within the scope of this disclosure.
    Type: Grant
    Filed: February 24, 2022
    Date of Patent: January 23, 2024
    Assignee: Purdue Research Foundation
    Inventors: Elizabeth I. Parkinson, Matthew A. Hostetler
  • BIOACTIVE PEPTIDE MOLECULES DISCOVERED BY A COMBINATION OF BIOINFORMATICS TECHNIQUE AND CHEMICAL SYNTHESIS
    Publication number: 20220282238
    Abstract: The present disclosure reaches a method of a unique combination of bioinformatic technical tools together with chemical synthesis for identification of bioactive peptide molecules based on non-ribosomal peptide synthetases. Those bioactive cyclic peptide molecules are useful as antimicrobials, anticancer agents, antiparasitic, immunosuppressants, and others. Series of useful cyclic peptides and the pharmaceutical compositions thereof are within the scope of this disclosure.
    Type: Application
    Filed: February 24, 2022
    Publication date: September 8, 2022
    Applicant: Purdue Research Foundation
    Inventors: Elizabeth I. Parkinson, Matthew A. Hostetler